Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,528,806 papers from all fields of science
Search
Sign In
Create Free Account
Hepatitis B Virus e Antibody Measurement
Known as:
HBEAB
, Hepatitis B Virus e Antibody
The determination of the amount of Hepatitis B virus e antibody present in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Antibody to hepatitis Be antigen
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A STUDY ON GENOTYPES OF HEPATITIS B VIRUS AMONG HEMODIALYSIS PATIENTS IN KHUZESTAN PROVINCE
Neisi Niloofar
,
Makvandi Manochehr
,
Samarbaf Zadeh Ali Reza
2011
Corpus ID: 32821492
Introduction and objective: Hepatitis B virus (HBV) is a member of Hepadnaviridae and a major causative agent of chronic and…
Expand
2008
2008
Optimization of the expression of hepatitis B virus e gene in Pichia pastoris and immunological characterization of the product.
Z. Li
,
Guoqiang Hong
,
Z. Wu
,
Bo Hu
,
Jue Xu
,
Lin Li
Journal of Biotechnology
2008
Corpus ID: 5105399
2005
2005
Serum neopterin levels in patients with chronic hepatitis B.
A. Kalkan
,
M. Ozden
,
H. Akbulut
Japanese journal of infectious diseases (Print)
2005
Corpus ID: 23017130
The aim of this study was to determine the neopterin levels and peripheral blood lymphocyte subgroups in HBeAg-positive and…
Expand
2004
2004
Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
Zhengxing Wang
,
Guoshan Ding
,
+5 authors
Z. Fu
Hepatobiliary & Pancreatic Diseases International
2004
Corpus ID: 23017862
2002
2002
[Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study].
S. Cui
,
Mingming Wang
,
Guiling Fan
Zhonghua yi xue za zhi
2002
Corpus ID: 3042429
OBJECTIVE To investigate the anti-HBV efficacy of bifendate in treatment of chronic hepatitis B. METHODS A total of 119…
Expand
2002
2002
Results of interferon treatment in children with chronic hepatitis B.
P. grigorescu-sido
,
Lazăr Călin
,
+4 authors
Anca Grigorescu-Sido
Romanian journal of gastroenterology
2002
Corpus ID: 23595297
Many observations report a variable therapeutical response to interferon in children with chronic hepatitis B. In order to…
Expand
1994
1994
[Exploration on the association between the pattern of HBV markers and infection of HCV among population].
W. Li
,
Y. Zhu
,
Z. Hua
Zhonghua liu xing bing xue za zhi = Zhonghua…
1994
Corpus ID: 40502029
Sera from 193 cases with positive HBV markers in April 1993 were detected for infection of HCV to explore the association between…
Expand
1994
1994
[Efficacy of Phyllanthus spp. in treating patients with chronic hepatitis B].
M. Wang
,
H. Cheng
,
Y. Li
,
L. Meng
,
K. Mai
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
1994
Corpus ID: 27966991
The efficacy of Phyllanthus amarus produced in india, P. niruri gathered from hainan province and P. urinaria from henan province…
Expand
1993
1993
Reactivation of hepatitis B virus in two chronic GVHD patients after transplant.
P. Chen
,
S. Fan
,
+4 authors
C. Tzeng
International journal of hematology
1993
Corpus ID: 26348564
We report two cases of hepatitis B virus reactivation following allogeneic bone marrow transplantation (BMT) for severe aplastic…
Expand
1993
1993
Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
W. Zielinska
,
J. Paszkiewicz
,
+5 authors
Georgiades Ja
Archivum Immunologiae et Therapiae Experimentalis
1993
Corpus ID: 45588509
The therapy concept is based on a theory of the immunocorrective effect of orally administered natural human interferon alpha in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE